AtriCure tentatively settles whistle-blower suit with Justice Department
AtriCure has agreed to pay $3.8 million over five years to settle allegations that it violated the False Claims Act regarding the marketing of its medical products. The tentative settlement "will allow us to focus on the business and executing our strategic priorities, including restoration of growth trends and increased shareholder value," said President and CEO David Drachman. AtriCure has denied any wrongdoing in the agreement.
American City Business Journals
| 11/4
This story published in AdvaMed SmartBrief on 11/05/2009
Get stories like these delivered daily for FREE:
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|